UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Can COVID‐19 in pregnancy cause pre‐eclampsia?

BJOG : an international journal of obstetrics and gynaecology, 2020-10, Vol.127 (11), p.1381-1381

Rolnik, DL

2020

Volltextzugriff (PDF)

Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

Ultrasound in obstetrics & gynecology, 2018-08, Vol.52 (2), p.186-195

2018

Volltextzugriff (PDF)

ASPRE trial: performance of screening for preterm pre‐eclampsia

Ultrasound in obstetrics & gynecology, 2017-10, Vol.50 (4), p.492-495

2017

Volltextzugriff (PDF)

How sFlt‐1 can help after pre‐eclampsia diagnosis

BJOG : an international journal of obstetrics and gynaecology, 2021-01, Vol.128 (2), p.166-166

2021

Volltextzugriff (PDF)

Maternal plasma cell‐free DNA in the prediction of pre‐eclampsia

Ultrasound in obstetrics & gynecology, 2015-01, Vol.45 (1), p.106-111

2015

Volltextzugriff (PDF)

Stillbirth: are we making more progress than we think? A retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2021-07, Vol.128 (8), p.1304-1312

2021

Volltextzugriff (PDF)

Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations

Ultrasound in obstetrics & gynecology, 2017-06, Vol.49 (6), p.756-760

2017

Volltextzugriff (PDF)

Successful pregnancy rates amongst patients undergoing ovarian tissue cryopreservation for non-malignant indications: A systematic review and meta-analysis

European journal of obstetrics & gynecology and reproductive biology, 2024-01, Vol.292, p.30-39

2024

Volltextzugriff (PDF)

Perinatal and neonatal outcomes of high-risk asymptomatic women from a specialist preterm birth surveillance clinic

European journal of obstetrics & gynecology and reproductive biology, 2024-05, Vol.296, p.114-119

2024

Volltextzugriff (PDF)

Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

Ultrasound in obstetrics & gynecology, 2017-06, Vol.49 (6), p.751-755

2017

Volltextzugriff (PDF)

Association between fetal fraction on cell‐free DNA testing and first‐trimester markers for pre‐eclampsia

Ultrasound in obstetrics & gynecology, 2018-12, Vol.52 (6), p.722-727

2018

Volltextzugriff (PDF)

Performance of QUiPP App v.2 tool for prediction of preterm birth in asymptomatic high‐risk women attending preterm specialist clinic: external validation study

Ultrasound in obstetrics & gynecology, 2024-07, Vol.64 (1), p.71-78

2024

Volltextzugriff (PDF)

Sonographic detection of fetal abnormalities before 11 weeks of gestation

Ultrasound in obstetrics & gynecology, 2020-05, Vol.55 (5), p.565-574

2020

Volltextzugriff (PDF)

EP18.03: ASPRE trial: effects of aspirin on serum PAPP‐A and PlGF trajectories in pregnancy

Ultrasound in obstetrics & gynecology, 2023-10, Vol.62 (S1), p.206-206

2023

Volltextzugriff (PDF)

OC19.05: ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy

Ultrasound in obstetrics & gynecology, 2023-10, Vol.62 (S1), p.45-45

2023

Volltextzugriff (PDF)

Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID‐19?

Ultrasound in obstetrics & gynecology, 2020-06, Vol.55 (6), p.843-844

2020

Volltextzugriff (PDF)

EP09.09: Treatment of fetal goiter in utero

Ultrasound in obstetrics & gynecology, 2023-10, Vol.62 (S1), p.149-149

2023

Volltextzugriff (PDF)

Impact of COVID‐19 pandemic restrictions on pregnancy duration and outcome in Melbourne, Australia

Ultrasound in obstetrics & gynecology, 2021-11, Vol.58 (5), p.677-687

2021

Volltextzugriff (PDF)

Influence of fibroids on cell‐free DNA screening accuracy

Ultrasound in obstetrics & gynecology, 2022-01, Vol.59 (1), p.114-119

2022

Volltextzugriff (PDF)

ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy

Ultrasound in obstetrics & gynecology, 2023-06, Vol.61 (6), p.691-697

2023

Volltextzugriff (PDF)

Uterine fibroids and non‐informative cell‐free DNA screening results

Ultrasound in obstetrics & gynecology, 2024-10, Vol.64 (4), p.463-469

2024

Volltextzugriff (PDF)

Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE

Ultrasound in obstetrics & gynecology, 2018-07, Vol.52 (1), p.52-59

2018

Volltextzugriff (PDF)

Pitfalls of systematic reviews and meta-analyses to assess the clinical utility of genomic investigations in prenatal diagnosis

Ultrasound in obstetrics & gynecology, 2024-07

2024

Volltextzugriff (PDF)

Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre‐eclampsia

Ultrasound in obstetrics & gynecology, 2022-05, Vol.59 (5), p.596-605

2022

Volltextzugriff (PDF)

ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis

Ultrasound in obstetrics & gynecology, 2021-10, Vol.58 (4), p.546-552

2021

Volltextzugriff (PDF)

1 – 25 von 171

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Pregnancy
(44)
Obstetrics & Gynecology
(42)
Ultrasonic Imaging
(29)
Female
(27)
Humans
(27)
Preeclampsia
(27)
Acoustics
(22)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Technology
(22)
Fetuses
(20)
Pre-Eclampsia
(19)
Obstetrics
(17)
Dioxole Derivatives
(16)
Aspirin
(14)
Biomarkers
(14)
Gestation
(14)
Gestational Age
(13)
Pre‐eclampsia
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Can COVID‐19 in pregnancy cause pre‐eclampsia?

Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

ASPRE trial: performance of screening for preterm pre‐eclampsia

How sFlt‐1 can help after pre‐eclampsia diagnosis

Maternal plasma cell‐free DNA in the prediction of pre‐eclampsia

Stillbirth: are we making more progress than we think? A retrospective cohort study

Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations

Successful pregnancy rates amongst patients undergoing ovarian tissue cryopreservation for non-malignant indications: A systematic review and meta-analysis

Perinatal and neonatal outcomes of high-risk asymptomatic women from a specialist preterm birth surveillance clinic

Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

Association between fetal fraction on cell‐free DNA testing and first‐trimester markers for pre‐eclampsia

Performance of QUiPP App v.2 tool for prediction of preterm birth in asymptomatic high‐risk women attending preterm specialist clinic: external validation study

Sonographic detection of fetal abnormalities before 11 weeks of gestation

EP18.03: ASPRE trial: effects of aspirin on serum PAPP‐A and PlGF trajectories in pregnancy

OC19.05: ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy

Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID‐19?

EP09.09: Treatment of fetal goiter in utero

Impact of COVID‐19 pandemic restrictions on pregnancy duration and outcome in Melbourne, Australia

Influence of fibroids on cell‐free DNA screening accuracy

ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy

Uterine fibroids and non‐informative cell‐free DNA screening results

Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE

Pitfalls of systematic reviews and meta-analyses to assess the clinical utility of genomic investigations in prenatal diagnosis

Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre‐eclampsia

ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis

Suchergebnisse filtern